PGC1α Expression Defines a Subset of Human Melanoma Tumors with Increased Mitochondrial Capacity and Resistance to Oxidative Stress

Barretina, 2012, The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity, Nature, 483, 603, 10.1038/nature11003

Bertolotto, 2011, A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma, Nature, 480, 94, 10.1038/nature10539

Bogunovic, 2009, Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival, Proc. Natl. Acad. Sci. USA, 106, 20429, 10.1073/pnas.0905139106

Chang, 2011, The metabolic regulator ERRα, a downstream target of HER2/IGF-1R, as a therapeutic target in breast cancer, Cancer Cell, 20, 500, 10.1016/j.ccr.2011.08.023

Choo, 2010, Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply, Mol. Cell, 38, 487, 10.1016/j.molcel.2010.05.007

Clark, 2000, Genomic analysis of metastasis reveals an essential role for RhoC, Nature, 406, 532, 10.1038/35020106

Cunningham, 2007, mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex, Nature, 450, 736, 10.1038/nature06322

Diehn, 2009, Association of reactive oxygen species levels and radioresistance in cancer stem cells, Nature, 458, 780, 10.1038/nature07733

Eichner, 2011, Estrogen related receptors (ERRs): a new dawn in transcriptional control of mitochondrial gene networks, Mitochondrion, 11, 544, 10.1016/j.mito.2011.03.121

Fernandez-Marcos, 2011, Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis, Am. J. Clin. Nutr., 93, 884S, 10.3945/ajcn.110.001917

Gao, 2009, c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism, Nature, 458, 762, 10.1038/nature07823

Garraway, 2005, Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma, Nature, 436, 117, 10.1038/nature03664

Grabacka, 2008, PPAR gamma regulates MITF and beta-catenin expression and promotes a differentiated phenotype in mouse melanoma S91, Pigment Cell Melanoma Res., 21, 388, 10.1111/j.1755-148X.2008.00460.x

Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013

Handschin, 2007, Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1alpha muscle-specific knock-out animals, J. Biol. Chem., 282, 30014, 10.1074/jbc.M704817200

Herzig, 2001, CREB regulates hepatic gluconeogenesis through the coactivator PGC-1, Nature, 413, 179, 10.1038/35093131

Hoek, 2008, In vivo switching of human melanoma cells between proliferative and invasive states, Cancer Res., 68, 650, 10.1158/0008-5472.CAN-07-2491

Kelly, 2004, Transcriptional regulatory circuits controlling mitochondrial biogenesis and function, Genes Dev., 18, 357, 10.1101/gad.1177604

Knutti, 2001, PGC-1, a versatile coactivator, Trends Endocrinol. Metab., 12, 360, 10.1016/S1043-2760(01)00457-X

Lerin, 2006, GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1alpha, Cell Metab., 3, 429, 10.1016/j.cmet.2006.04.013

Lin, 2002, Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres, Nature, 418, 797, 10.1038/nature00904

Lin, 2008, Modeling genomic diversity and tumor dependency in malignant melanoma, Cancer Res., 68, 664, 10.1158/0008-5472.CAN-07-2615

Moffat, 2006, A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen, Cell, 124, 1283, 10.1016/j.cell.2006.01.040

Mootha, 2003, PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes, Nat. Genet., 34, 267, 10.1038/ng1180

Mootha, 2004, Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle, Proc. Natl. Acad. Sci. USA, 101, 6570, 10.1073/pnas.0401401101

Ohta, 2008, Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth, Cancer Res., 68, 1303, 10.1158/0008-5472.CAN-07-5003

Padmanabhan, 2006, Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer, Mol. Cell, 21, 689, 10.1016/j.molcel.2006.01.013

Puigserver, 2003, Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator, Endocr. Rev., 24, 78, 10.1210/er.2002-0012

Puigserver, 1998, A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis, Cell, 92, 829, 10.1016/S0092-8674(00)81410-5

Raj, 2011, Selective killing of cancer cells by a small molecule targeting the stress response to ROS, Nature, 475, 231, 10.1038/nature10167

Rhee, 2003, Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis, Proc. Natl. Acad. Sci. USA, 100, 4012, 10.1073/pnas.0730870100

Riker, 2008, The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis, BMC Med. Genomics, 1, 13, 10.1186/1755-8794-1-13

Sahin, 2011, Telomere dysfunction induces metabolic and mitochondrial compromise, Nature, 470, 359, 10.1038/nature09787

Scarpulla, 2011, Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network, Biochim. Biophys. Acta, 1813, 1269, 10.1016/j.bbamcr.2010.09.019

Schreiber, 2004, The estrogen-related receptor alpha (ERRalpha) functions in PPARgamma coactivator 1alpha (PGC-1alpha)-induced mitochondrial biogenesis, Proc. Natl. Acad. Sci. USA, 101, 6472, 10.1073/pnas.0308686101

Sen, 2011, PGC-1α, a key modulator of p53, promotes cell survival upon metabolic stress, Mol. Cell, 44, 621, 10.1016/j.molcel.2011.08.044

Shibata, 2008, Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy, Proc. Natl. Acad. Sci. USA, 105, 13568, 10.1073/pnas.0806268105

Singh, 2006, Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer, PLoS Med., 3, e420, 10.1371/journal.pmed.0030420

St-Pierre, 2006, Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators, Cell, 127, 397, 10.1016/j.cell.2006.09.024

Strub, 2011, Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma, Oncogene, 30, 2319, 10.1038/onc.2010.612

Subramanian, 2005, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc. Natl. Acad. Sci. USA, 102, 15545, 10.1073/pnas.0506580102

Tait, 2010, Mitochondria and cell death: outer membrane permeabilization and beyond, Nature Rev. Mol. Cell Biol., 11, 621, 10.1038/nrm2952

Trachootham, 2006, Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate, Cancer Cell, 10, 241, 10.1016/j.ccr.2006.08.009

Trachootham, 2009, Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?, Nat. Rev. Drug Discov., 8, 579, 10.1038/nrd2803

Weinberg, 2009, Mitochondrial metabolism and cancer, Ann. N Y Acad. Sci., 1177, 66, 10.1111/j.1749-6632.2009.05039.x

Wende, 2005, PGC-1alpha coactivates PDK4 gene expression via the orphan nuclear receptor ERRalpha: a mechanism for transcriptional control of muscle glucose metabolism, Mol. Cell. Biol., 25, 10684, 10.1128/MCB.25.24.10684-10694.2005

Wise, 2008, Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction, Proc. Natl. Acad. Sci. USA, 105, 18782, 10.1073/pnas.0810199105

Yokoyama, 2011, A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma, Nature, 480, 99, 10.1038/nature10630

Zaugg, 2011, Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress, Genes Dev., 25, 1041, 10.1101/gad.1987211